// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

The Use of IVIG in a Complicated Case of Rheumatoid Arthritis

Aurore Fifi-Mah - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Congestive heart failure

Hydroxychloroquine

The Association of Femoral Acetabular Impingement and Delayed Gadolinium Enhanced MRI of Cartilage (dGEMRIC): A Population-based Study

Honglin Zhang - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Systemic Sclerosis Severity as a Singular Metric: Using Item Response Theory on Medsgers Disease Severity Scales

Russell Steele - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Scleroderma

N/A

Adherence to a Treat-To-Target Strategy is Key to Attainment of Sustained Remission in Rheumatoid Arthritis: Data from the Real-world Practice BIODAM Cohort

Maggie Larche - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

The Impact of Obesity on Remission and Disease Outcomes in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

Gilaad Kaplan - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Rheumatoid arthritis

N/A

Ischemic Complications in Takayasus Arteritis: A Meta-Analysis

Diana Golverk - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Myocardial infarction

N/A

Interferon Gone Wrong: A Case Report of a Child Presenting with Polyarthritis and Chilblains Due to a SAMHD1 Gene Mutation

Ann Yeh - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Erythema multiforme

fusidic acid

A Comparison of Current Practice to New Vasculitis Treatment Guidelines

Elaine Yacyshyn - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Prednisone

Case Presentation: PRES in the Setting of Goodpasture Disease Treated With Cyclophosphamide

Mala Joneja - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Posterior Reversible Encephalopathy Syndrome

Methylprednisolone

Childhood Diffuse Alveolar Hemorrhage

Marinka Twilt - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Modification of Structural Lesions on Magnetic Resonance Imaging by Etanercept: A 12- week Randomized Placebo-Controlled Trial

Stephanie Wichuk - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Spondyloarthritis

Etanercept

Risk Factors for Poor Health-Related Quality of Life in Children with Inflammatory Brain Diseases

Marinka Twilt - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

From Childhood to Adulthood: Identifying Latent Classes of Disease Activity Trajectories in Childhood-onset Systemic Lupus Erythematosus Patients

Eleanor Pullenayegum - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Prednisone

Chronic Recurrent Multifocal Osteomyelitis (CRMO) and Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Syndrome: A Report of Four Cases and Review of the Literature

Christopher Penney - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Chronic recurrent multifocal osteomyelitis

N/A

Medication Adherence in Systemic Lupus Erythematosus: A Systematic Review

Mohammad Atiquzzaman - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

Defining the Optimal 14-3-3? Threshold to Predict Worse Radiographic Outcomes in Patients with Recent-Onset Inflammatory Arthritis

Anthony Marotta - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Longitudinal, Incremental Direct Medical Costs of Lupus Nephritis amongst a General Population-Based Cohort of Systemic Lupus Erythematosus

Carlo Marra - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

Proof of Concept Study of the Arthritis Health Journal: An Online Tool to Promote SelfMonitoring in People with Rheumatoid Arthritis (RA)

Erin Carruthers - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Intravenous Immunoglobulin for the Treatment of Idiopathic Inflammatory Myopathies A Survey of Canadian Physicians

Pari Basharat - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Idiopathic inflammatory myopathies

IVIG

Risk Factors for Appointment Non-Attendance at an Academic Rheumatology Clinic

Shirley Chow - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved